JAK2V617F mutation and allele burden are associated with distinct clinical and morphological subtypes in patients with essential thrombocythaemia

Journal of Clinical Pathology

Volumn 65, Issue 10, 2012, Pages 953-955

  Pich, Achille ^a   Riera, Ludovica ^a,b   Beggiato, Eloise ^c   Nicolino, Barbara ^c   Godio, Laura ^a   Campisi, Paola ^a   Sismondi, Francesca ^b   Di Celle, Paola Francia ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER;

ADULT; AGED; ALLELE; ARTERY THROMBOSIS; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; GENE MUTATION; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; PRIORITY JOURNAL; SPLENOMEGALY; THROMBOCYTHEMIA; ULTRASOUND; VEIN THROMBOSIS;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; BIOPSY; BONE MARROW; COST OF ILLNESS; FEMALE; HOMOZYGOTE; HUMANS; JANUS KINASE 2; MALE; MEGAKARYOCYTES; MIDDLE AGED; THROMBOCYTHEMIA, ESSENTIAL;

EID: 84866853490     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2012-200804     Document Type: Letter

References (8)

1. Thiele J, Kvasnicka HM, Orazi A, et al. Essential thrombocythaemia. In: Swerdlow SH, Campo E, Harris NL, et al. eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th edn. Lyon: IARC Press, 2008:48-50.
2. Antonioli E, Guglielmelli P, Poli G, et al. Influence of JAK2V617F allele burden on phenotype in essential thrombocythemia. Haematologica 2008;93:41-8. (Pubitemid 351156150)
3. Campbell PJ, Scott LM, Buck G, et al. Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study. Lancet 2005;366:1945-53. (Pubitemid 41713984)
4. Lussana F, Caberlon S, Pagani C, et al. Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: a systematic review. Thromb Res 2009;124:409-17.
5. Vannucchi AM, Antonioli E, Guglielmelli P, et al. Clinical profile of homozygous JAK2V617F mutation in patients with polycythemia vera or essential thrombocythemia. Blood 2007;110:840-6. (Pubitemid 47267419)
6. Kittur J, Knudson RA, Lasho TL, et al. Clinical correlates of JAK2V617F allele burden in essential thrombocythemia. Cancer 2007;109:2279-84. (Pubitemid 46801558)
7. Palandri F, Ottaviani E, Salmi F, et al. JAK2 V617F mutation in essential thrombocythemia: correlation with clinical characteristics, response to therapy and long-term outcome in a cohort of 275 patients. Leuk Lymphoma 2009;50:247-53.
8. Carobbio A, Finazzi G, Antonioli E, et al. JAK2V617F allele burden and thrombosis: a direct comparison in essential thrombocythemia and polycythemia vera. Exp Hematol 2009;37:1016-21.